spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Constella 

 HSMN NewsFeed - 27 Feb 2025
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2020
ABM Respiratory Care Raises US$10.3M in Series A Funding Round and Appoints Peter H. Soderberg as Chairman of the Board of Directors
Devices Venture Capital Personnel
 HSMN NewsFeed - 4 Oct 2019
Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 19 Dec 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2018
Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jul 2018
Alcon introduces NGENUITY(R) 3D Visualization System with DATAFUSION(TM) to simplify, customize vitreoretinal surgery
Devices Ophthalmology Surgery Product Launch
 HSMN NewsFeed - 23 Feb 2018
VoCare Develops the World's First Mobile Professional Grade Medical Multi-Diagnostic Device, Which Provides a Revolutionary Integrated Mobile Point-of-Care Solution as Well as a Remote Patient Monitoring Solution
Devices Monitoring
 HSMN NewsFeed - 13 Feb 2018
Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 May 2017
Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 29 Mar 2016
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2014
Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 14 May 2013
Third Rock Ventures Expands and Strengthens Team
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 29 Apr 2013
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2013
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&D
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 11 Jun 2012
Veteran Medical Technology Executive and Industry Expert Peter Soderberg Invests in EarlySense and Joins the Company’s Board of Directors
Devices Monitoring Venture Capital Personnel
 HSMN NewsFeed - 27 Mar 2012
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Jun 2011
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2011
Asuragen Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe
Diagnostics Regulatory
 HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2011
23andMe Announces Additional Investment in Series C Financing; Dr. Ashley Ledbetter Dombkowski of MPM Capital Joins 23andMe's Board of Directors
Personalized Medicine Venture Capital Personnel
 HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel
 HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Mar 2010
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Jan 2010
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Sep 2009
Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company's CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2007
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 25 Jul 2007
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2007
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2007
DiObex Announces the Appointment of David Cory as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2007
OraSure Technologies Signs Agreement for Development of Counseling and Referral System for Home Use Rapid HIV Test Kit
Diagnostics
 HSMN NewsFeed - 22 Feb 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 29 Sep 2006
Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2006
ALTANA AG: Sale of Pharmaceuticals Business to Nycomed
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
Constella
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.